|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
36
|
|
pubmed:dateCreated |
2006-12-20
|
|
pubmed:abstractText |
Several phase II studies have suggested that cytarabine (AraC) was not required in the treatment of newly diagnosed acute promyelocytic leukemia (APL) patients receiving all-trans-retinoic acid (ATRA), an anthracycline, and maintenance therapy, and we aimed at confirming this finding in a randomized trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AdèsLionelL,
pubmed-author:ChevretSylvieS,
pubmed-author:ChomienneChristineC,
pubmed-author:DeconinckEricE,
pubmed-author:DegosLaurentL,
pubmed-author:DombretHerveH,
pubmed-author:European Acute Promyelocytic Leukemia Group,
pubmed-author:FegueuxNathalieN,
pubmed-author:FenauxPierreP,
pubmed-author:FerrantAugustinA,
pubmed-author:GuerciAgnesA,
pubmed-author:LamyThierryT,
pubmed-author:MaloiselFredericF,
pubmed-author:Meyer-MonardSandrineS,
pubmed-author:PigneuxArnaudA,
pubmed-author:RaffouxEmmanuelE,
pubmed-author:Rigal-HuguetFrancoiseF,
pubmed-author:StoppaAnne MarieAM,
pubmed-author:ThomasXavierX,
pubmed-author:VekhoffAnneA,
pubmed-author:de BottonStephaneS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5703-10
|
|
pubmed:meshHeading |
pubmed-meshheading:17116939-Adult,
pubmed-meshheading:17116939-Antimetabolites, Antineoplastic,
pubmed-meshheading:17116939-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17116939-Cytarabine,
pubmed-meshheading:17116939-Daunorubicin,
pubmed-meshheading:17116939-Drug Administration Schedule,
pubmed-meshheading:17116939-Female,
pubmed-meshheading:17116939-Humans,
pubmed-meshheading:17116939-Leukemia, Promyelocytic, Acute,
pubmed-meshheading:17116939-Male,
pubmed-meshheading:17116939-Middle Aged,
pubmed-meshheading:17116939-Remission Induction,
pubmed-meshheading:17116939-Survival Analysis,
pubmed-meshheading:17116939-Tretinoin
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
|
|
pubmed:affiliation |
Assistance Publique-Hôpitaux de Paris, Hôpital Avicenne, Service d'Hématologie Clinique, Paris 13 University, Bobigny, France.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
